BNTX BioNTech SE

NASDAQ
$96.85

BioNTech SE (BNTX) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is $0.82 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.8% since its last earnings release on August 4, 2026.

BioNTech SE Missed Consensus Estimates, Lowers Guidance
Tuesday, August 4, 2026 · 6:45 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 6:45 AM ET
Earnings Whisper
-
vs $0.82
Rev est $1.21B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $103.22

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BioNTech SE

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.

Sector

Healthcare

Industry

Biotechnology

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.